| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Carmot Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $594.61M | Series E | 5/25/2023 | $150M | $696.68M | $23.01 | Deep Track Capital, 5AM Ventures, Franklin Templeton, Frazier Life Sciences, Janus Henderson Investors, Millenium Management, TCGX, Venrock Healthcare Capital Partners, RA Capital Management, The Column Group, Willett Advisors | ||||
 | CB Insights | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Center | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $178.56M | Series C | 11/13/2023 | $50M | $521.9M | $6.41 | Undisclosed Investors | ||||
 | CereVasc | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $198.48M | Series C-3 | 6/4/2026 | $26.43M | $275.83M | $1.04 | Piper Sandler, Johnson & Johnson, Medtronic, Bain Capital, Perceptive Advisors | ||||
 | Certify | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70.45M | Series B | 6/26/2025 | $40M | $271.73M | $13.23 | Transformation Capital, General Catalyst, Upfront Ventures, SemperVirens Venture Capital | ||||
 | Charisma.ai | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Cherre | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $427.02M | Series C | 9/18/2024 | $30M | $145.73M | $0.53 | HighSage Ventures, Nuveen Real Estate, RXR, TA Realty, Trustbridge Partners, Glilot Capital Partners, Intel Capital, Carthona Capital | ||||
 | ClearDATA | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $160.84M | Series E | 11/19/2018 | $26M | $220.91M | $0.77 | Excel Venture Management, Flare Capital Partners, HCSC Ventures, Heritage Group, HLM Venture Partners, Merck Global Health Innovation Fund | ||||
 | Clockwork Systems | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $42.1M | Series A-1 | 9/10/2025 | $20.5M | $357M | $4.96 | New Enterprise Associates, Lip-Bu Tan, John Chambers, Carl Ledbetter, e& Capital, JC2 Ventures | ||||
 | Cloudinary | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Cogent Security | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.6M | Series A | 2/18/2026 | $44.35M | $310.35M | $6.04 | Bain Capital, Greylock Partners, Definition, 515 Ventures, Artisanal Ventures, Lockstep | ||||
 | CognitiveScale | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $51.81M | Series B-1 | 6/13/2017 | $8.29M | $239.36M | $6.85 | Norwest Venture Partners, Intel Capital, Microsoft Ventures, The Westly Group, USAA | ||||
 | Coinbase | Fintech Blockchain | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $529.76M | Series E | 10/26/2018 | $300M | $8.06B | $36.19 | Tiger Global Management, Andreessen Horowitz, GIC, Y Combinator, Polychain Capital, Silver 8 Capital, A.Capital Ventures, Serena Ventures, Trousdale Ventures Eudaimonia Capital, Pritzker Group Venture Capital, Wellington Management | ||||
 | Collate | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $125.5M | Series A | 6/3/2026 | $95M | $724.46M | $43.78 | Redpoint, First Round Capital, Conviction Partners, Y Combinator | ||||
 | ColorChip | Consumer & Lifestyle Consumer Electronics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Commons | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Convergent Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $130M | Series A-4 | 9/24/2024 | $40M | $269.38M | $2.01 | Novo Holdings | ||||
 | Conviva | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $483.75K | -- | 2 | Not available | -- | -- | $123.16M | Series F | 6/15/2017 | $40M | $307.37M | $2.13 | Australia Future Fund, New Enterprise Associates, Foundation Capital, Time Warner Investments | ||||
 | ConXtech | Real Estate Other Real Estate | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Corvidia Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Crayon | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Crossover Health | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $281.51M | Series D | 3/29/2021 | $168M | $1.17B | $35.56 | Deerfield Management Company, Perceptive Advisors, OrbiMed Advisors, Foresite Capital, Avidity Partners, Private Shares Fund, Irving Investors, PFM Health Sciences | ||||
 | Curve | Fintech Digital Banking | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Cyemptive | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||